Publications by authors named "Rut Porta"

Claim this Profile
C
Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study.
Javier Trujillo-Santos, Ignacio García-Escobar, Mercedes Salgado, António Araújo, Eva Martínez-de-Castro, Rut Porta

Oncologist· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models.
Emma Polonio-Alcalá, Rut Porta, Santiago Ruiz-Martínez, Carmen Vásquez-Dongo, Joana Relat

Biomed Pharmacother· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polycaprolactone Electrospun Scaffolds Produce an Enrichment of Lung Cancer Stem Cells in Sensitive and Resistant EGFRm Lung Adenocarcinoma.
Emma Polonio-Alcalá, Marc Rabionet, Santiago Ruiz-Martínez, Sònia Palomeras, Rut Porta

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial.
Rafael Rosell, Urania Dafni, Enriqueta Felip, Alessandra Curioni-Fontecedro, Oliver Gautschi, Rut Porta

Lancet Respir Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR a promising druggable target in cancer: Molecular biology and new drugs.
Rut Porta, Roberto Borea, Andreia Coelho, Shahanavaj Khan, António Araújo

Crit Rev Oncol Hematol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin.
Joaquim Bosch-Barrera, Elia Sais, Noemí Cañete, Jordi Marruecos, Elisabet Cuyàs, Rut Porta

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemoradiotherapy Treatment for a Classic Biphasic Pulmonary Blastoma with High PD-L1 Expression.
Joaquim Bosch-Barrera, Francia Holguin, Xavier Baldó, Matilde Rubio, Rut Porta

Anticancer Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic limbic encephalitis in a male with squamous cell carcinoma of the lung.
Tamara Sauri, Àngel Izquierdo, LLuis Ramió-Torrentà, Àngel Sanchez-Montañez, Joaquim Bosch-Barrera, Rut Porta

J Clin Neurol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of ALK status by FISH on 1000 Spanish non-small cell lung cancer patients.
Joana Vidal, Sergi Clavé, Silvia de Muga, Iria González, Lara Pijuan, Rut Porta

J Thorac Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful empirical erlotinib treatment of a mechanically ventilated patient newly diagnosed with metastatic lung adenocarcinoma.
Joaquim Bosch-Barrera, Elia Sais, Carol Lorencio, Rut Porta, Angel Izquierdo

Lung Cancer· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty acid synthase expression is strongly related to menopause in early-stage breast cancer patients.
Rut Porta, Adriana Blancafort, Gemma Casòliva, Miquel Casas, Joan Dorca

Menopause· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Oxidative stress in patients with cancer: two sides of the same coin].
Gemma Viñas, Teresa Puig, Rut Porta

Med Clin (Barc)· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
Rafael Rosell, Enric Carcereny, Radj Gervais, Alain Vergnenegre, Bartomeu Massuti, Rut Porta

Lancet Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Complications of intramuscular metastasis in a patient with lung cancer].
Rut Porta, Sebastián Remollo, Angel Izquierdo, Ramón Colomer

Med Clin (Barc)· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive biomarkers in the management of EGFR mutant lung cancer.
Rafael Rosell, Teresa Moran, Felipe Cardenal, Rut Porta, Santiago Viteri

Ann N Y Acad Sci· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for epidermal growth factor receptor mutations in lung cancer.
Rafael Rosell, Teresa Moran, Cristina Queralt, Rut Porta, Felipe Cardenal

N Engl J Med· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Fatty acid synthase: a new anti-tumor target].
Teresa Puig, Rut Porta, Ramon Colomer

Med Clin (Barc)· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.
Teresa Puig, Alejandro Vázquez-Martín, Joana Relat, Jordi Pétriz, Javier A Menéndez, Rut Porta

Breast Cancer Res Treat· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer.
Li Yang, Joseph M Amann, Takefumi Kikuchi, Rut Porta, Marta Guix

Cancer Res· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism.
Li Yang, Yuhui Huang, Rut Porta, Kiyoshi Yanagisawa, Adriana Gonzalez

Cancer Res· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis